{"id": "NCT00002602", "sem_title": "radiation therapy in treating patients with stage ii or stage iii prostate cancer", "brief_summary": "['rationale: radiation therapy uses high-energy x-rays to damage tumor cells and may be an effective treatment for prostate cancer. purpose: phase i/ii trial to study the effectiveness of radiation therapy in treating patients who have previously untreated stage ii or stage iii prostate cancer.']", "brief_summary_entities": [{"id": ["BERN:256225101"], "span": {"begin": 65, "end": 70}, "obj_text": "tumor", "obj": "disease"}, {"id": ["OMIM:176807", "MESH:D011471", "BERN:107535701"], "span": {"begin": 115, "end": 130}, "obj_text": "prostate cancer", "obj": "disease"}, {"id": ["BERN:255913301"], "span": {"begin": 257, "end": 294}, "obj_text": "stage ii or stage iii prostate cancer", "obj": "disease"}], "detailed_description": "['disease characteristics: previously untreated adenocarcinoma of the prostate t1b-c or t2a-b with a gleason score more than 5 and psa greater than 4 ng/ml or any t3 psa under 70 ng/ml within 3 weeks prior to entry and at least 10 days after prostate biopsy no biopsy proven regional nodal involvement no distant metastases patient characteristics: age: 18 and over performance status: karnofsky 80-100% hematopoietic: white blood cell (wbc) count of at least 4,000/mm3 platelet count at least 100,000/mm3 hemoglobin at least 11 g/dl hepatic: not specified renal: not specified other: no major medical or psychiatric illness that would preclude study no other malignancy within the past 5 years prior concurrent therapy: biologic therapy: not specified chemotherapy: no prior or concurrent chemotherapy endocrine therapy: prior hormonal therapy allowed radiotherapy: no prior pelvic irradiation surgery: no prior prostatectomy or cryosurgery for prostate cancer']", "detailed_description_entities": [{"id": ["BERN:258242501"], "span": {"begin": 48, "end": 78}, "obj_text": "adenocarcinoma of the prostate", "obj": "disease"}, {"id": ["MIM:610936", "HGNC:19129", "Ensembl:ENSG00000135069", "BERN:323582402"], "span": {"begin": 131, "end": 134}, "obj_text": "psa", "obj": "gene"}, {"id": ["MIM:610936", "HGNC:19129", "Ensembl:ENSG00000135069", "BERN:323582402"], "span": {"begin": 166, "end": 169}, "obj_text": "psa", "obj": "gene"}, {"id": ["CUI-less"], "span": {"begin": 437, "end": 440}, "obj_text": "wbc", "obj": "gene"}, {"id": ["BERN:326403602"], "span": {"begin": 506, "end": 516}, "obj_text": "hemoglobin", "obj": "gene"}, {"id": ["MESH:D001523", "BERN:254324401"], "span": {"begin": 594, "end": 624}, "obj_text": "medical or psychiatric illness", "obj": "disease"}, {"id": ["BERN:258004301"], "span": {"begin": 660, "end": 670}, "obj_text": "malignancy", "obj": "disease"}, {"id": ["OMIM:176807", "MESH:D011471", "BERN:107535701"], "span": {"begin": 946, "end": 961}, "obj_text": "prostate cancer", "obj": "disease"}], "eligibility_criteria": "['disease characteristics: previously untreated adenocarcinoma of the prostate t1b-c or t2a-b with a gleason score more than 5 and psa greater than 4 ng/ml or any t3 psa under 70 ng/ml within 3 weeks prior to entry and at least 10 days after prostate biopsy no biopsy proven regional nodal involvement no distant metastases patient characteristics: age: 18 and over performance status: karnofsky 80-100% hematopoietic: white blood cell (wbc) count of at least 4,000/mm3 platelet count at least 100,000/mm3 hemoglobin at least 11 g/dl hepatic: not specified renal: not specified other: no major medical or psychiatric illness that would preclude study no other malignancy within the past 5 years prior concurrent therapy: biologic therapy: not specified chemotherapy: no prior or concurrent chemotherapy endocrine therapy: prior hormonal therapy allowed radiotherapy: no prior pelvic irradiation surgery: no prior prostatectomy or cryosurgery for prostate cancer']", "eligibility_criteria_entities": [{"id": ["BERN:258242501"], "span": {"begin": 48, "end": 78}, "obj_text": "adenocarcinoma of the prostate", "obj": "disease"}, {"id": ["MIM:610936", "HGNC:19129", "Ensembl:ENSG00000135069", "BERN:323582402"], "span": {"begin": 131, "end": 134}, "obj_text": "psa", "obj": "gene"}, {"id": ["MIM:610936", "HGNC:19129", "Ensembl:ENSG00000135069", "BERN:323582402"], "span": {"begin": 166, "end": 169}, "obj_text": "psa", "obj": "gene"}, {"id": ["CUI-less"], "span": {"begin": 437, "end": 440}, "obj_text": "wbc", "obj": "gene"}, {"id": ["BERN:326403602"], "span": {"begin": 506, "end": 516}, "obj_text": "hemoglobin", "obj": "gene"}, {"id": ["MESH:D001523", "BERN:254324401"], "span": {"begin": 594, "end": 624}, "obj_text": "medical or psychiatric illness", "obj": "disease"}, {"id": ["BERN:258004301"], "span": {"begin": 660, "end": 670}, "obj_text": "malignancy", "obj": "disease"}, {"id": ["OMIM:176807", "MESH:D011471", "BERN:107535701"], "span": {"begin": 946, "end": 961}, "obj_text": "prostate cancer", "obj": "disease"}]}